Halo Genomics Signs Co-Marketing Agreement with Life Technologies to Combine Target Enrichment Kits with Next-Generation Sequencing Platforms

Document -

Halo Genomics Signs Co-Marketing Agreement with Life Technologies to Combine Target Enrichment Kits with Next-Generation Sequencing Platforms

UPPSALA, Sweden, April 4- Halo Genomics, an Uppsala based genomics company, today announced that it has signed a co-marketing agreement with Life Technologies Corporation making Halo Genomics’ target enrichment technology a recommended method for target enrichment with Life Technologies next-generation sequencing product line 5500 SOLiD™ Series.
go to media item
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
File format:
.pdf
Download

Contacts

Olle Ericsson

Press contact CEO, Co-founder +46 18 495 31 20

Related content

Halo Genomics Signs Co-Marketing Agreement with Life Technologies to Combine Target Enrichment Kits with Next-Generation Sequencing Platforms

UPPSALA, Sweden, April 4- Halo Genomics, an Uppsala based genomics company, today announced that it has signed a co-marketing agreement with Life Technologies Corporation making Halo Genomics’ target enrichment technology a recommended method for target enrichment with Life Technologies next-generation sequencing product line 5500 SOLiD™ Series.